Success Metrics

Completion Rate
0%(0/2)
Active Trials
2(40%)
Terminated
2(40%)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_2
2
40%
Ph phase_3
2
40%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Terminated(2)
Other(1)

Detailed Status

Active, not recruiting2
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (40.0%)
Phase 32 (40.0%)
N/A1 (20.0%)

Trials by Status

active_not_recruiting240%
unknown120%
terminated240%

Recent Activity

2 active trials
Showing 5 of 5
active_not_recruitingphase_2

A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection

NCT01419067
terminatedphase_3

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

NCT06125028
active_not_recruitingphase_2

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

NCT02125786
terminatednot_applicable

FDG-PET in Advanced Melanoma

NCT02236546
unknownphase_3

18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology

NCT01180751

Clinical Trials (5)

Showing 5 of 5 trials
NCT01419067Phase 2

A Phase II Trial of Limited Surgery and Proton Therapy for Craniopharyngioma or Observation After Radical Resection

Active Not Recruiting
NCT06125028Phase 3

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

Terminated
NCT02125786Phase 2

A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma

Active Not Recruiting
NCT02236546Not Applicable

FDG-PET in Advanced Melanoma

Terminated
NCT01180751Phase 3

18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5